Anavex Life Sciences Corp. SEC filings AVXL
Anavex Life Sciences Corp. has 634 filings in SEC EDGAR's recent list, going back to Jan 13, 2005. Its latest annual report, Form 10-K, was filed on Nov 25, 2025 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 28, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 28, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Aug 28, 2026 | Mar 31, 2026 |
| 10-Q/A | Amended quarterly report | Aug 28, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Feb 9, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Feb 12, 2025 | Dec 31, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Feb 7, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Feb 7, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Feb 9, 2022 | Dec 31, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Feb 16, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Feb 6, 2020 | Dec 31, 2019 |
| 10-Q | Quarterly report | Aug 7, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 9, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Feb 7, 2019 | Dec 31, 2018 |
| 10-Q | Quarterly report | Aug 9, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 10, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Feb 7, 2018 | Dec 31, 2017 |
| 10-Q | Quarterly report | Aug 7, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 10, 2017 | Mar 31, 2017 |
| 10-Q | Quarterly report | Feb 7, 2017 | Dec 31, 2016 |
| 10-Q | Quarterly report | Aug 11, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 11, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Feb 8, 2016 | Dec 31, 2015 |
| 10-Q | Quarterly report | Aug 14, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | May 14, 2015 | Mar 31, 2015 |
| 10-Q | Quarterly report | Feb 17, 2015 | Dec 31, 2014 |
| 10-Q | Quarterly report | Aug 13, 2014 | Jun 30, 2014 |
| 10-Q/A | Amended quarterly report | May 30, 2014 | Mar 31, 2014 |
| 10-Q | Quarterly report | May 14, 2014 | Mar 31, 2014 |
| 10-Q | Quarterly report | Feb 14, 2014 | Dec 31, 2013 |
| 10-Q | Quarterly report | Aug 14, 2013 | Jun 30, 2013 |
| 10-Q | Quarterly report | May 17, 2013 | Mar 31, 2013 |
| 10-Q | Quarterly report | Feb 14, 2013 | Dec 31, 2012 |
| 10-Q | Quarterly report | Aug 17, 2012 | Jun 30, 2012 |
| 10-Q | Quarterly report | May 15, 2012 | Mar 31, 2012 |
| 10-Q | Quarterly report | Feb 14, 2012 | Dec 31, 2011 |
| 10-Q | Quarterly report | Aug 12, 2011 | Jun 30, 2011 |
| 10-Q | Quarterly report | May 16, 2011 | Mar 31, 2011 |
| 10-Q | Quarterly report | Feb 14, 2011 | Dec 31, 2010 |
| 10-Q | Quarterly report | Aug 20, 2010 | Jun 30, 2010 |
| 10-Q | Quarterly report | May 21, 2010 | Mar 31, 2010 |
| 10-Q | Quarterly report | Feb 22, 2010 | Dec 31, 2009 |
| 10-Q | Quarterly report | Aug 19, 2009 | Jun 30, 2009 |
| 10-Q | Quarterly report | May 20, 2009 | Mar 31, 2009 |
| 10-Q | Quarterly report | Feb 23, 2009 | Dec 31, 2008 |
| 10-Q/A | Amended quarterly report | May 15, 2006 | Mar 31, 2006 |
| 10-Q | Quarterly report | May 15, 2006 | Mar 31, 2006 |
Showing 58 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AVXL (Nasdaq)
- Fiscal year ends
- September 30
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer, Smaller reporting company
- SEC CIK
- 1314052
- Former names
- Thrifty Printing Inc. (until Jan 25, 2007)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.